Other financial obligations comprise the following:
| [ XLS ] |
€ million |
Dec. 31, |
thereof |
Dec. 31, |
thereof |
Obligations to acquire intangible assets |
1,247.7 |
– |
246.9 |
– |
Orders for capital expenditure on property, plant and equipment |
76.3 |
– |
25.2 |
– |
Future rental payments |
62.9 |
– |
64.8 |
– |
Future operating lease payments |
87.4 |
– |
48.3 |
– |
Long-term purchase commitments |
0.3 |
– |
0.3 |
– |
Other financial obligations |
30.9 |
– |
13.0 |
– |
|
1,505.5 |
– |
398.5 |
– |
Obligations to acquire intangible assets exist in particular within the scope of research and development collaborations. Here Merck has obligations to make milestone payments when its partner achieves certain objectives. In the unlikely event that all contract partners achieve all milestones, Merck would be obligated to pay up to €1,247.7 million (2006: €246.9 million) for the acquisition of intangible assets. The obligations are as follows:
| [ XLS ] |
€ million |
potential |
potential |
potential |
Total |
Obligations to acquire intangible assets |
78.7 |
423.7 |
745.3 |
1,247.7 |
Other financial obligations are carried at nominal value. Liabilities from lease agreements are composed as follows:
| [ XLS ] |
€ million |
Remaining |
Remaining |
Remaining |
Total |
Present value of future payments from finance leases |
1.0 |
8.9 |
– |
9.9 |
Interest component of finance leases |
– |
0.5 |
– |
0.5 |
Future finance lease payments |
1.0 |
9.4 |
– |
10.4 |
|
|
|
|
|
Future operating lease payments |
22.0 |
45.3 |
20.1 |
87.4 |
